explore -WSS

explore

author：hotspot 2025-09-04 04:29:09 - browse：161

James Comer -- coverage from STAT — Rep. James Comer, chair of the House Oversight Committee Kevin Dietsch/Getty Images

WASHINGTON — Congress wants to reform PBM business practices to help lower the cost of medicines — but don’t think they’ve forgotten drugmakers have a role in high drug prices.

Two lawmakers, including a Republican, questioned PhRMA Chief Operating Officer Lori Reilly about just how much her group was spending on its major campaigns against PBMs this year. Both Reps. Summer Lee (D-Pa.) and Eric Burlison (R-Mo.) used their time to question drugmakers over their spending on lawsuits against Medicare drug price negotiation and ad campaigns against pharmacy benefit managers.

Although Lee started off bashing PBMs for the fees they charge drugmakers, she quickly aimed her fire back on pharma. She said brand drugmakers charge Americans double what they charge other countries, and she asked why several drugmakers are suing the federal government over Medicare’s drug price negotiation.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Heart attack and stroke risk calculators need revising
Next article： Keeping primary care docs in field isn't impossible, says AAFP CEO

knowledge

WSS

Why health care costs have stayed mostly flat since 2010

Carvykti CAR

SNAP should offer more nutrition education

A bus careens into a gulch in southern Mexico, leaving 27 people dead

Three trends to watch in biotech in 2024

How to keep neuroscience’s past racism from being its future

explore

explore

focus

Psychedelics group wrestles with new pharma identity

HCA sued by state AG for quality issues at Mission Health

Cancer drug shortages should be causing more outrage

Can sheer will power keep patients alive in their dying hours?

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Violet CEO on training clinicians to promote more inclusive care

Duchenne breakthrough therapy leaves behind pioneering families

Hospitals owned by private equity see complications spike 25%

Walensky prepares to leave CDC — and Congress — behind

SEC charges former device maker CEO with $41 million fraud

focus

Gov. Ron DeSantis' push for 'civics' education: What does it look like?

Dramatic video released of Russian fighter jets 'harassing' US drones over Syria

Three trends to watch in biotech in 2024

Israel withdraws forces after 2

1 in 4 Americans hadn't contracted COVID by the end of 2022, CDC estimates

Violet CEO on training clinicians to promote more inclusive care

focus

knowledge

hotspot

hotspot